Glasgow 2026

Glasgow 2026
November 08-11, 2026
Glasgow, UK

HIV Glasgow 2026.

Explore more information for Gilead HIV / AIDS therapies
Material Type
Filter by Keyword(s)

Filter results with keywords such as:

  • Name of author(s)
  • Disease state
  • Indication
  • Trial phase
  • Trial name
  • Trial date

Note: Multiple keywords can be applied at the same time.

    Results (19)

    Phenotypic Analyses of HIV Clinical Isolates with Capsid Substitutions Observed in the PURPOSE 1 and PURPOSE 2 Studies

    • Author(s): Hendricks, M
    • yeztugo
    • HIV / AIDS

    Understanding Treatment Experiences with Weekly Oral Islatravir/Lenacapavir in the Phase 3 ISLEND-2 Study: Participant and Provider Interviews

    • Author(s): Orkin, C
    • isl/len
    • HIV / AIDS

    Bictegravir/Lenacapavir: Baseline and Week 48 Resistance in the ARTISTRY-2 Study

    • Author(s): D'Antoni, ML
    • bixlenvo
    • HIV / AIDS

    Quality of Life and Treatment Preference with Weekly ISL/LEN Versus Standard of Care: Week 48 Patient-Reported Outcome Analysis of the Phase 3 ISLEND-2 Study

    • Author(s): Ramgopal, M
    • isl/len
    • HIV / AIDS

    Higher Persistence on Twice-yearly LEN versus Daily F/TDF for PrEP in the UK and France in the PURPOSE 5 study

    • Author(s): Orkin, C
    • yeztugo
    • HIV / AIDS

    Characterising Viremic Events in the ARTISTRY-1 and ARTISTRY-2 Trials

    • Author(s): Ruane, P
    • bixlenvo
    • HIV / AIDS

    BICSTaR: 24-month Effectiveness and Tolerability of B/F/TAF by HIV diagnosis era

    • Author(s): Levy, I
    • biktarvy
    • HIV / AIDS

    Examining the Healthcare Burden of Antiretroviral Therapy Resistance Among People with HIV in the United States

    • Author(s): Tookes, H
    • biktarvy
    • HIV / AIDS

    Antiviral Activity, Pharmacokinetics, and Safety of Oral GS-3242 for HIV-1 Treatment

    • Author(s): Gupta, S
    • gs-3242
    • HIV / AIDS

    Referral from Post-Exposure Prophylaxis to Pre-Exposure Prophylaxis in the United States, 2016 - 2025: An Analysis of Real World Claims Data

    • Author(s): Mayer, K
    • biktarvy
    • HIV / AIDS

    Community HERO Treatment Survey: Understanding Drivers of Treatment Satisfaction and Adherence among Cis Women with HIV

    • Author(s): Lu, YC
    • biktarvy
    • HIV / AIDS

    Patient-Reported Outcomes in Treatment-Naïve People With HIV Initiating B/F/TAF: A Pooled Analysis of the BICSTaR Cohort

    • Author(s): Trottier, B
    • biktarvy
    • HIV / AIDS

    Identifying and Characterising People with HIV Who Are Virologically Suppressed and Receiving Complex Regimens in Spain: The CoRIS Cohort

    • Author(s): Jarrin, I
    • bixlenvo
    • HIV / AIDS

    Once-weekly oral Islatravir/Lenacapavir (ISL/LEN) versus daily standard of care (SOC) across participant subgroups through Week 48 in the Phase 3 ISLEND-2 trial

    • Author(s): Parczewski, M
    • isl/len
    • HIV / AIDS

    Virological Outcomes of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) Through Week 48 in Children and Infants Aged ≥1 Month and Weighing ≥3 to <25 kg

    • Author(s): Rakhmanina, N
    • biktarvy
    • HIV / AIDS

    Characterising Resistance-Associated Mutations and Virological Status Among People Living with HIV Receiving Regimens Containing Bictegravir, Cabotegravir, or Dolutegravir

    • Author(s): Levintow, S
    • biktarvy
    • HIV / AIDS

    Efficacy and safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) Tablet for Oral Suspension (TOS) in Children and Infants Aged ≥1 Month, Weighing 3 to <25 kg: Week 48 (W48) Outcomes

    • Author(s): Parczewski, M
    • biktarvy
    • HIV / AIDS

    Once-weekly Oral Islatravir/Lenacapavir (ISL/LEN) versus daily Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in virologically suppressed adults with HIV-1: Week 48 subgroup analyses of the Phase 3 ISLEND-1 trial

    • Author(s): Rockstroh, J
    • isl/len
    • HIV / AIDS

    Demographics, Clinical Characteristics, and Treatment Patterns of People with HIV Who are Virologically Suppressed Receiving Complex Regimens in Japan: A Real-World Database Study Using Electronic Medical Records

    • Author(s): Navadeh, S
    • bixlenvo
    • HIV / AIDS